Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis

International Journal of Urology

Volumn 13, Issue 11, 2006, Pages 1380-1384

  Aybek, Hulya ^b   Aybek, Zafer ^b   Sinik, Zafer ^a,b   Demir, Suleyman ^b   Sancak, Burak ^b   Tuncay, Levent ^b  

^a Ortopedi ve Travmatoloji   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

CA 19 9; Hydronephrosis; Tumor markers; Urine

Indexed keywords

CA 19-9 ANTIGEN; CREATININE;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYDRONEPHROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; URINARY TRACT OBSTRUCTION;

ADULT; AGED; CA-19-9 ANTIGEN; CREATININE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDRONEPHROSIS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; UROLOGIC DISEASES;

EID: 33750431881     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01593.x     Document Type: Article

References (16)

1. Burtis CA, Ashwood ER. Tumor markers. In: Chan DW, Sell S (eds). Tietz Textbook of Clinical Chemistry. W.B. Saunders Company, Philadelphia, USA, 1999; 722-50.
2. Lawrence AK, Amadeo JP. Neoplasia. In: Bernard ES, Per W (eds). Clinical Chemistry Theory, Analysis, and Correlation. The C. V. Mosby Company, St. Louis, USA, 1989; 735.
3. Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res. 1982; 42: 4820-3.
4. Arends JW, Verstynen C, Bosman FT, Hilgers J, Steplewski Z. Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma 1983; 2: 219-29.
5. Vestergaard EM, Wolf H, Orntoft TF. Increased concentrations of genotype-interpreted Ca 19-9 in urinary of bladder cancer patients mark diffuse atypia of the urothelium. Clin. Chem. 1998; 44: 197-204.
6. Meyer A, Kausch I, Kruger S, fetscher S, Bohle A, Jockham D. Elevation of Ca 19-9 in giant hydronephrosis induced by a renal calculus. Urology 2004; 63: 381-2.
7. Suzuki K, Muraishi O, Tokue A. The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis. J. Urol. 2002; 167: 16-20.
8. Minghini A, Weireter LJ Jr, Perry RR. Specificity of elevated CA 19-9 levels in chronic pancreatitis. Surgery 1998; 124: 103-5.
9. Buccheri GF, Ferrigno D, Sartoris AM, Violante B, Vola F, Curcio A. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9. Cancer 1987; 60: 42-50.
10. Koea J, Holden A, Chau K, McCall J. Differential diagnosis of stenosing lesions at the hepatic hilus. World J. Surg. 2004; 28: 466-70.
11. Katsanos KH, Kitsanou M, Christodoulou DK, Tsianos EV. High CA 19-9 levels in benign biliary tract diseases. Report of four cases and review of the literature. Eur. J. Intern. Med. 2002; 13: 132-5.
12. Frykholm G, Enblad P, Pahlman L, Busch C. Expression of the carcinoma-associated antigens CA 19-9 and CA-50 in inflammatory bowel disease. Dis. Colon Rectum 1987; 30: 545-8.
13. Imai A, Horibe S, Takagi A, Takagi H, Tamaya T. Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 1998; 78: 79-81.
14. Petit JM, Vaillant G, Olsson NO et al. Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group. Gastroenterol. Clin. Biol. 1994; 18: 17-20.
15. Ammon A, Eiffert H, Weber MH, Rummel J, Niemann J. Tumor markers in dialysis-dependent renal failure. A comparison of the mucin-like carcinoma antigen, CA 15-3, CA 125, CA 19-9 and CEA antigens. Onkologie 1988; 11: 260-2.
16. Bossi MC. The kidney and adrenal glands. In: Goldberg B, Pettersson H (eds). The 1996 NICER Year Book Ultrasongraphy. The NICER Institute, Oslo, 1996; 187-220.